Summary
| Direction in ME/CFS | ↓ Reduced — lower than in the comparison group |
|---|---|
| Category | Functional |
| Also described as | Functional capacity |
| Compared against | HC (healthy controls) |
| Associated symptoms | Activity limitation |
| Test type | Clinical or physiological test |
| Source | Maksoud et al. 2023 — doi:10.1186/s12916-023-02893-9 |
| Condition atlas | ME/CFS Biomarker Atlas |
Other conditions where 6-minute walk distance is reported
| Atlas entry | Direction | Compared against |
|---|---|---|
| 6-minute walk distance in Gulf War Illness | ↓ reduced | vs HGV |
| 6-minute walk distance in PACVS | ↓ reduced | vs HC |
See the cross-condition hub: 6-minute walk distance across conditions.
Trials, interventions and tests
In clinical-trial registrations this marker maps to the outcome term Functional Capacity (25 registered trials use a matching outcome measure).
Clinical trials using 6-minute walk distance as an outcome
17 more trials reference this marker.
Interventions studied alongside this marker
Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.
- Exercise therapy — 3 trials, 6 PubMed co-citations
e.g. Effects of Telerehabilitation Based on Motion Recognition Technology on Exercise Endurance of Patients With… - Cognitive rehabilitation — 2 trials, 6 PubMed co-citations
e.g. Randomised active controlled trial examining effects of aerobic exercise, cognitive and music interventions… - Pyridostigmine — 1 trial, 1 PubMed co-citations
e.g. Elevated Heart Rate is Associated with Cardiac Denervation in Patients with Heart Failure: A 123-Iodine-MIBG… - Low-dose naltrexone — 1 trial, 1 PubMed co-citations
e.g. Effect of Naltrexone on Spinal and Supraspinal Pain Mechanisms and Functional Capacity in Women with… - Cardiopulmonary Rehabilitation — 1 trial, 6 PubMed co-citations
e.g. Effectiveness of Early Cardiorespiratory Rehabilitation Combined With Melatonin Supplementation During the… - Acceptance and commitment therapy — 1 trial, 1 PubMed co-citations
e.g. Acceptability and feasibility of acceptance and commitment therapy for improving outcomes in hematopoietic… - Transcranial direct current stimulation — 1 trial, 6 PubMed co-citations
e.g. Home-Based Transcranial Direct Current Stimulation for Menstrual Pain and Premenstrual Symptoms: A… - Motor Training — 1 trial, 4 PubMed co-citations
e.g. Lower limb sensory training improves functional capacity in hemiparesis: a single-blinded randomized…
Related Functional markers in ME/CFS
Full list: ME/CFS Biomarker Atlas.
Frequently asked questions
Is 6-minute walk distance high or low in ME/CFS?
Reduced. Studies summarised in the OSMF atlas report lower 6-minute walk distance in ME/CFS than in healthy controls. Source: Maksoud et al. 2023.
What symptoms is 6-minute walk distance associated with in ME/CFS?
The cited literature associates this marker with Activity limitation. These are population-level associations and do not mean the marker causes the symptoms.
Which test measures 6-minute walk distance?
It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal 6-minute walk distance result diagnostic of ME/CFS?
No. No single biomarker is diagnostic of ME/CFS. 6-minute walk distance findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Is 6-minute walk distance specific to ME/CFS?
No. The same marker is also reported in Gulf War Illness, PACVS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.
Cite this page
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.